Keeping psoriatic arthritis under control

Written by: Dr Joel David
Edited by: Cameron Gibson-Watt

Up to 15% of people who have psoriasis may develop psoriatic arthritis – a progressive and challenging form of arthritis. It can have a huge impact on people’s lives and cause long-lasting damage to your joints. Nowadays, thanks to modern medication, it’s possible to relieve symptoms and stop the disease in its tracks.

Dr Joel David, a leading rheumatologist, explains to us more about this disease and what treatment is out there.

What is psoriatic arthritis?

Psoriatic arthritis (PsA) is a type of inflammatory arthritis (as opposed to a degenerative arthritis), which results in the joints becoming swollen and painful. It can start suddenly or develop over a couple of weeks. It often occurs in individuals who already have psoriasis or those who have a first degree relative with psoriasis. It is not unusual to develop in a joint that has had a recent injury - this is known as the Knoebner phenomenon.



The psoriatic skin manifestations might be very subtle. The severity of the skin disease does not necessarily mirror the severity of the joint disease. In fact, there may only be slight pitting of the nails, or some presence of dandruff on the scalp. Flakey reddish skin in the ears, belly button, and genital area, around the cleft between the buttocks or on the soles of the feet may be present.


Psoriatic arthritis appears in different forms:

  • Non-symmetrical arthritis – this often involves the terminal joints of the fingers or toes. When there is swelling of the whole finger or toe it is referred to as a dactylitis. Large joints such as the knees, ankles and elbowmay also be affected.
  • Symmetrical joint arthritis – this is similar to rheumatoid arthritis, meaning that both hands and feet are affected.
  • Spinal involvement – it can appear in the neck, temporomanibular joints (joints connecting the jawbone to the skull) and the sacroiliac joints (joints in the pelvis). Sometimes the shoulders and hips can be affected.
  • Arthritis mutilans – this is a rare and very destructive form causing inflammation in the terminal joints of the fingers and also the nails. This leads to damage and deformation of the affected areas.
  • Gout – this is more common in people who suffer from psoriasis and is caused by excess uric acid in the bloodstream.

When the joints are affected there is pain, stiffness and swelling, which is usually worse in the mornings. If left untreated, the joints may become permanently damaged.


How is psoriatic arthritis treated?

The main aim of the treatment is to slow the progression of the condition, prevent permanent damage, relieve symptoms and improve patients’ quality of life.


A rheumatologist may decide on administering steroid injections directly to the joint. If there are multiple joints affected or the condition does not respond to local treatment, then disease modifying therapy (DMARDs) are considered. These drugs can slow the progression of psoriatic arthritis and save the joints from permanent damage.


The most common type of DMARDs is methotrexate – an anti-rheumatic drug which reduces the activity of the overactive immune system. Other DMARDs include salazopyrine and leflunomide. If these are ineffective, then biological therapies with monoclonal antibodies might be used. These include anti-TNF drugs (adalimumab or etanercept) or IL-17 inhibitors such as secukinumab. For severe skin disease, urstikinumab is considered, which stops the action of cells in the body that cause the symptoms of psoriatic arthritis.


Can psoriatic arthritis go away?

Starting treatment as soon as possible could make lasting remission very likely. In general, the outlook is good - although the drugs may need to be continued long-term. The systemic effects of the arthritis are extremely rare - in contrast to rheumatoid, where lung and other system involvement can occur.


If you already have or are suspicious that you are developing PsA, visit Dr Joel David‘s profile and book an appointment.

By Dr Joel David

Dr Joel David is a distinguished senior consultant rheumatologist based in Oxford. He specialises in treating rheumatoid, psoriatic, and juvenile arthritis and is also renowned for his expertise in ankylosing spondylitis, lupus and gout, among other conditions. He sees private patients at his own practice, Joel David Rheumatology.

Dr David qualified in medicine from University of the Witwatersrand, South Africa in 1981. After an internship in Johannesburg, he relocated to London to take up a general medicine position at the Royal Free Hospital before undertaking postgraduate training in rheumatology at the Royal Postgraduate Medical School, Hammersmith Hospital. He was appointed as a member of the Royal College of Physicians (MRCP) in 1984 and later a fellow in 1996 (FRCP). He undertook senior registrar positions at Charing Cross, Northwick Park and Great Ormond Street Hospitals and was appointed as a consultant rheumatologist in 1992 at the Royal Berkshire Hospitals NHS Trust in Reading. He currently holds the position of senior consultant rheumatologist and clinical lead at Nuffield Orthopaedic Centre and sees private patients at his own practice in Oxford.

Dr David is a leading name in the field of rheumatology and was responsible for setting up OxPARC (Oxford Paediatric and Adolescent Rheumatology Centre) and oxsport@noc, a state-of-the-art sport and exercise medicine department in Oxfordshire. He worked in conjunction with experts in the fields of ophthalmology and endocrinology to set up a national referral centre for autoimmune thyroid eye disease and also helps run multi-disciplinary joint clinics in complex auto-immune disease, collaborating closely with specialists in haematology, immunology and respiratory medicine.

Dr David has held a number of senior positions throughout his career and currently serves as regional specialty advisor for rheumatology and rheumatology governance lead for the Oxford region and is a former clinical director and clinical lead in medicine. His extensive academic publications are published in peer-reviewed journals and he also plays a key role in education for medical trainees, being a senior lecturer at University of Oxford Medical School and an examiner for the Royal College of Physicians.

View Profile

Overall assessment of their patients

  • Related procedures
  • Platelet-rich plasma
    Ozone therapy
    Neuropathic pain
    Elbow Pain
    Knee osteoarthritis
    Growth factors
    Trapped nerve
    Spinal osteoarthritis
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.